SCHEMBL30825510

SCHEMBL30825510

CC1(F)CNCCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22179895 0.80 MEN1 (0.40)
SCHEMBL1692392 0.76
SCHEMBL15648680 0.76
Hydrochloric Acid SCHEMBL17837260 0.74 MEN1 (0.38)
SCHEMBL25046791 0.73
SCHEMBL31451776 0.73
SCHEMBL16906325 0.73
SCHEMBL31328779 0.73
SCHEMBL9109002 0.72 MEN1 (0.53)
Hydrochloric Acid SCHEMBL25373969 0.71 MEN1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250019377-A1 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2025-01-16 US disclosed
WO-2024063576-A1 NOVEL QUINAZOLINE COMPOUND AS KRAS INHIBITOR 일동제약(주) 2024-03-28 WO disclosed